Dianthus Therapeutics (DNTH) Non-Current Deffered Revenue (2022 - 2025)
Dianthus Therapeutics' Non-Current Deffered Revenue was $5.77 million in Q4 2025, up 202.4% from $1.91 million a year earlier but down 4.9% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Non-Current Deffered Revenue (2022 - 2025) Analysis & Trends
From Q4 2022 onward, Dianthus Therapeutics has reported Non-Current Deffered Revenue for 11 quarters.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of 93.9% (FY2022 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $1.91 million in FY2024 (+159.2%), $736,000 in FY2023 (-7.0%) and $791,000 in FY2022.
- Quarterly Non-Current Deffered Revenue has moved between $640,000 (Q3 2024) and $6.07 million (Q3 2025) over five years.
- Compared with a year earlier, Non-Current Deffered Revenue has increased for five straight quarters, with growth averaging 252.5% over the last six quarters.
- Per Business Quant data, DNTH's Non-Current Deffered Revenue in the three quarters before Q4 2025 was $6.07 million (Q3 2025), $1.79 million (Q2 2025) and $1.85 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Dianthus Therapeutics | 3.77 Bn | 3.72 Bn | - | 5.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5.77 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 640,000.00 |
| Jun 30, 2024 | 682,000.00 |
| Mar 31, 2024 | 719,000.00 |
| Dec 31, 2023 | 736,000.00 |
| Sep 30, 2023 | 745,000.00 |
| Dec 31, 2022 | 791,000.00 |
API Access
Dianthus Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();